Baillie Gifford - CHINA BIOLOGIC PRODS INC ownership

Quarter-by-quarter ownership
Baillie Gifford ownership history of CHINA BIOLOGIC PRODS INC
ValueSharesWeighting
Q2 2017$155,794,000
+11.5%
1,377,493
-1.3%
0.21%
+3.4%
Q1 2017$139,709,000
-8.0%
1,395,284
-1.3%
0.20%
-18.8%
Q4 2016$151,931,000
-15.4%
1,413,045
-2.1%
0.25%
-11.0%
Q3 2016$179,643,000
+15.7%
1,443,152
-1.2%
0.28%
+1.4%
Q2 2016$155,307,0001,460,7520.28%
Other shareholders
CHINA BIOLOGIC PRODS INC shareholders Q3 2023
NameSharesValueWeighting ↓
SPQ Asia Capital Ltd 228,777$24,597,00012.30%
Ariose Capital Management Ltd 238,841$25,680,0008.36%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 8,400$903,0003.21%
RUDMAN ERROL M 37,001$3,978,0002.76%
INDUS CAPITAL PARTNERS, LLC 167,104$17,967,0002.33%
Ativo Capital Management LLC 90,748$9,757,0002.30%
THOMAS WHITE INTERNATIONAL LTD 130,130$13,991,0002.08%
OBERWEIS ASSET MANAGEMENT INC/ 55,855$6,006,0001.80%
Cormorant Asset Management, LP 112,867$12,135,0001.64%
BARING ASSET MANAGEMENT Ltd 143,512$15,430,0001.06%
View complete list of CHINA BIOLOGIC PRODS INC shareholders